Drug Treatment in Schizophrenia *

Affleck J. W. , Cooper A. J. , Forrest A. D. , Smythies J. R. , and Zealley A. K. : Penicillamine and schizophrenia — a clinical trial. Brit. J. Psychiat. 115: 173–176, 1969.

Albert J. M. , Palaic D. , Tetreault L. , Panisset J. C. , Dhaiti G. , and Desaty J. : Effect of thioproperazine on 5-HIAA content in urine and cerebrospinal fluid of chronic schizophrenic patients. Dis. Nerv. Syst. 31(11): 140–144, 1970.

Ban T. A. : Conditioning and Psychiatry. Chicago, Aldine Publishing Co., 1964.

Bleuler E. P. (1911): Dementia Praecox or the Group of Schizophrenias, (trans. Zinkin, J.). New York, International Universities Press, 1950.

Brodsky L. : A biochemical survey of schizophrenia. Canad. Psychiat. Ass. J. 15(4): 375–388, 1970.

Casey J. F. , Bennett I. F. , Lindley C. J. , Hollister L. E. , Gordon M. H. , and Springer N. N. : Drug therapy in schizophrenia: A controlled study of the relative effectiveness of chlorpromazine, promazine, phenobarbital and placebo. Arch. Gen. Psychiat. 2: 210–220, 1960a.

Casey J. F. , Lasky J. J. , Klett C. J. , and Hollister L. E. : Treatment of schizophrenic reactions with phenothiazine derivatives. Amer. J. Psychiat. 117: 97–105, 1960b.

Cawley R. H. : “The present status of physical methods of treatment of schizophrenia.” In: Copen A. , and Walk A. (eds.): Recent Developments in Schizophrenia. Ashford, Headley Brothers Limited, 1967.

Charalampous K. D. , and Brown S. : A clinical trial of α-methyl-para-tyrosine in mentally ill patients. Psychopharmacologia (Bed) 11: 422–429, 1967.

Cole J. O. , Goldberg S. , and Davies J. : “Drugs in the treatment of psychosis: controlled studies”. In: Solomon P. (ed.): Psychiatric Drugs. New York, Grune and Stratton, 1966.

Curry S. H. , Davis J. M. , Janowsky D. S. , and Marshall J. H. L. : Factors affecting chlorpromazine plasma levels in psychiatric patients. Arch. Gen. Psychiat. 22(3): 209–215, 1970a.

Curry S. H. , Marshall J. H. L. , Davis J. M. , and Janowsky D. S. : Chlorpromazine plasma levels and effects. Arch. Gen. Psychiat. 22(4): 289–296, 1970b.

Domino E. F. : “Pharmacological analysis of the pathobiology of schizophrenia.” In: Silva Sankar D. V. (ed.): Schizophrenia: Current Concepts and Research. Hicks-ville, P.J.D. Publications, 1969.

Gaddum J. H. (1954): In, Smythies, J. R.: Introduction: In, Himwich H. E. , Kety S. S. , and Smythies J. E. (eds.): Amines and Schizophrenia. London, Pergamon Press, 1967.

Gallant D. M. , and Bishop M. P. : Cinanserin (SQ 10,643): A preliminary evaluation in chronic schizophrenic patients. Curr. Ther. Res. 10(9): 461–463, 1968.

Gastaut H. : Etat actuel des connaissances sur l'electroencephalographie du conditionnement. Electroenceph. Clin. Neurophysiol. Suppl. 6, 1957.

Gershon S. , Hekimian L. J. , Floyd A. Jr. , and Hollister L. E. : α-methyl-p-tyrosine (AMT) in schizophrenia. Psychopharmacologia (Berl) Suppl. 11, 1967.

Goldberg S. C. , Klerman G. D. , and Cole J. O. : Changes in schizophrenic psychopathology and ward behaviour as a function of phenothiazine treatment. Brit. J. Psychiat. 111: 120–133, 1965.

Goldberg S. C. , Mattsson N. , Cole J. O. , and Klerman G. L. : Prediction of improvement in schizophrenia under four phenothiazines. Arch. Gen. Psychiat. 16: 107–117, 1967.

Goldstein M. , Anagnoste B. , Lauber E. , and McKereghan M. R. : Inhibition of dopamine-β-hydroxylase by disulfiram. Life Sci. 3: 763–767, 1964.

Green D. E. , and Forrest Irene S. : In vivo metabolism of chlorpromazine. Canad. Psychiat. Ass. J. 11: 299–302, 1966.

Greiner A. C. : Schizophrenia and the pineal gland. Canad. Psychiat. Ass. J. 15: 433–447, 1970.

Greiner A. C. , and Nicolson G. A. : Schizophrenia — melanosis — cause or side effect. Lancet ii: 1165–1167, 1965.

Hamon J. , Paraire J. , and Velluz J. : Remarques sur l'action du 4560 RP sur l'agitation maniaque. Ann. Médicopsychol. (Paris) 110(1): 331–335, 1952.

Heath R. G. , Nesselhof W. , Bishop M. P. , and Byers L. W. : Behavioral and metabolic changes associated with administration of tetraethylthiuram disulfide. Dis. Nerv. Syst. 26: 99–105, 1965.

Helmchen H. , Hippius H. , Hoffman I. , and Seibach H. : D-penicillamin in der schizophrenia-behandlung. Vorläufige mitteilung. Nervenarzt. 38: 218, 1967.

Herkett E. E. , and Keup W. : Excretion patterns of tryptamine, indoleacetic acid, and 5-hydroxyindoleacetic acid, and their correlation with mental changes in schizophrenic patients under medication with alpha methyldopa. Psychopharmacologia (Berl) 15: 48–59, 1969.

Hollister L. E. , Moore F. F. , Forrest F. , and Bennett J. L. : Antipyridoxine effect of d-penicillamine in schizophrenic men. Amer. J. Clin. Nutr. 19: 307–312, 1966.

Jarvik M. E. : “Drugs used in the treatment of psychiatric disorders.” In: Goodman L. S. , and Gilman A. (eds.): The Pharmacological Basis of Therapeutics. Toronto, MacMillan, 1965.

Klein D. F. , and Davis J. M. : Diagnosis and Drug Treatment of Psychiatric Disorders. Baltimore, The Williams and Wilkins Company, 1969.

Marks J. : Predrug behavior as a predictor of response to phenothiazines among schizophrenics. J. Nerv. Ment. Dis. 137: 597–601, 1963.

Medical Letter: Antipsychotic drugs and their major adverse effects. Medical Letter on Drugs and Therapeutics 12(25): 104, 1970.

Musacchio J. , Koplin I. J. , and Snyder S. : Effects of disulfiram on tissue norepinephrine content and subcellular distribution dopamine, tyramine and their β-hydroxylated metabolites. Life Sci. 3: 769–775, 1964.

Pavlov I. P. : Lectures on Conditioned Reflexes. Translated by Gantt, W. H. New York, International Publishers, 1928.

Pecknold J. C. , Ananth J. V. , Ban T. A. , and Lehmann H. E. : The use of methyldopa in schizophrenia: A review and comparative study (in press).

Platz A. R. , Klett J. , and Caffey E. M. Jr. : Selective drug action related to chronic schizophrenic subtype. (A comparative study of carphenazine, chlorpromazine and trifluoperazine). Dis. Nerv. Syst. 28: 601–605, 1967.

Snezhnevsky A. V. : Psychopharmacology and psychiatry. Int. J. Psychiat. 1: 219–28, 1965.

St. Jean A. , Ban T. A. , and Noe W. : Psychopharmacological studies with neoserp and aldomet. Int. J. Neuropsychiat. 1(5): 491–503, 1965.

Woolley D. W. : The Biochemical Basis of Psychoses. New York, Wiley, 1962.

Woolley D. W. , and Shaw E. : A biochemical and pharmacological suggestion about certain mental disorders. Science 119: 587–588, 1954.